Nationwide Baxter Heparin Recall Alert

Send to Friend | Bookmark | Live Chat

Baxter Healthcare Corporation has issued an urgent Nationwide Recall of Heparin, as it has been linked to serious, life-threatening side effects including allergic reactions and death.

If you or a loved one have been administered Baxter manufactured Heparin and since suffered from and allergic reaction or any other related side effects including death, you should contact us immediately. You may be entitled to compensation and we can help.

What’s the problem?

RECENT UPDATE: On 2/29/08, the New York Times reported that the blood thinner Heparin, might be tied to more deaths. Amid indications that more people may have died or been harmed after being given a brand of the blood thinner Heparin, federal drug regulators said Thursday that they had found “potential deficiencies” at a Chinese plant that supplied much of the active ingredient for the drug.

According to the U.S. Food & Drug Administration, the number of deaths possibly associated with the drug, made from pig intestines, had risen to 21 from 4.

Furthermore, the FDA has admitted that it had violated its own policy by failing to inspect SPL, the Chinese plant in question, before the factory began shipping Heparin ingredients to Baxter in 2004. China’s drug agency also did not inspect the plant.

The problems with Heparin, which is used to prevent blood clotting during dialysis and after some surgery, were first reported last month at a hospital in Missouri. Since then, the number of reported adverse reactions has risen to 448, the F.D.A. said.

February 29, 2008 - Baxter Heparin Recall Notice

February 29, 2008 - FDA Recall
"Baxter to Proceed with Recall of Remaining Heparin Sodium Vial Products"

January 25, 2008 Baxter Heparin Recall Notice

February 11, 2008 - FDA Advisory
"Baxter's Multiple-dose Vial Heparin Linked to Severe Allergic Reactions"

On January 25, 2008, Baxter Healthcare Corporation has announced the voluntary recall of nine lots of Heparin sodium injection 1000 units/mL 10mL and 30mL multi-dose vials. The company began recalling the lots on January 17, 2008 as a precautionary measure due to an increase in the number of reports of adverse patient reactions that may be associated with the product.
The original January Baxter Heparin Recall cited adverse event reports including the following: stomach pain or discomfort, nausea, vomiting, diarrhea, decreased or low blood pressure, chest pain, fast heart rate, dizziness, fainting, unresponsiveness, shortness of breath, feeling your heart beat strong or fast, drug ineffectiveness, burning sensation, redness or paleness of skin, abnormal sensation of the skin, mouth or lips, flushing, increased sweating, decreased skin sensitivity, headache, feeling unwell, restlessness, watery eyes, throat swelling, thirst and difficulty opening the mouth. Some of these reactions may be severe or life threatening.

February 11, 2008 Baxter Heparin Recall Notice

January 25, 2008 - FDA Advisory
"Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/ml 10 and 30ml Multi-Dose Vials"

On February 11, 2008, Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug Heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high "bolus" doses of the drug.

“Serious reactions to the drug have included difficulty breathing, nausea, vomiting, excessive sweating, and rapidly falling blood pressure that can lead to life-threatening shock. Four people have died after receiving Heparin, although the relationship to the drug is unclear.”

Do I have a Baxter Heparin Recall Lawsuit?

The Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Baxter Heparin Recall lawsuits. We are handling individual litigation nationwide and currently accepting new Heparin cases in all 50 states.

Attention Attorneys: We do not publish prior verdict/settlements. If you are an attorney and would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.

= Required Field

Baxter Heparin Recall News (National)

FDA warns Chinese over heparin recall - The Washington Times The Chinese manufacturer of an ingredient in the blood thinner heparin does not have adequate systems for ensuring that the raw materials it uses are safe and that any impurities are removed, the Food and Drug Administration said yesterday. The FDA ... Contaminated Heparin Associated with Adverse Clinical Events and ... - New England Journal of Medicine Background There is an urgent need to determine whether oversulfated chondroitin sulfate (OSCS), a compound contaminating heparin supplies worldwide, is the cause of the severe anaphylactoid reactions that have occurred after intravenous heparin ... FDA sees more Heparin deaths, expands recall - Baltimore Sun WASHINGTON - Expanding the scope of its Heparin recall, the government is sending letters to 82 medical device makers today warning them to withdraw any stents, catheters and other products that might contain the contaminated blood thinner. The move ... HEPARIN RECALL - Dallas Morning News WASHINGTON ? Expanding the scope of its heparin recall, the government is sending letters to 82 medical device makers today warning them to withdraw any stents, catheters and other products that might contain the contaminated blood thinner. The ... Seeking alternatives to animal-derived drugs - International Herald Tribune Chopped pig pancreas may not sound appetizing. But most cystic fibrosis patients eat a refined version of it each breakfast, lunch and dinner ? five large capsules a meal ? to supply enzymes their bodies do not produce. The pills are life ... Md. native's expertise led to drug recall - Baltimore Sun WASHINGTON - On Jan. 4, Dr. Alexis M. Elward, a troubleshooter at St. Louis Children's Hospital, was summoned to investigate severe allergic reactions in two children undergoing dialysis there. Elward -- an Annapolis native trained in Maryland ... LegalView Reports on Prominent Montana Democrat's Demand for Funds to ... - PR.com One of Montana's top Democrats has demanded that the federal government allocate funds to clean up an asbestos-ridden town housing a former vermiculite mine. Libby, Montana is the site of the former W R Grace & Co mine, declared a Superfund site by ... LegalView Reports Mine Safety and Health Administration's Reduction of ... - PR.com LegalView alerted mesothelioma blog readers of lowered asbestos exposure allowances, which were amended by the Mine Safety and Health Administration recently. The new limits were reduced by 95 percent of original limits and could increase the number ... China places responsibility on U.S. in heparin recall - Chicago Tribune SHANGHAI - China's drug safety agency, commenting on a probe into the recalled medication heparin, said Wednesday that it enforces strict controls on chemicals used in pharmaceuticals but importing countries are ultimately responsible for ensuring ... Earnings Preview: Baxter to report 1Q results after recall - Boston Globe NEW YORK? Drug and medical device maker Baxter International Inc. reports its first-quarter results on Thursday. The following is a summary of key developments and analyst commentary for the period OVERVIEW: Baxter's quarter was dominated by the ...